Company Simulations Plus, Inc.

Equities

SLP

US8292141053

Advanced Medical Equipment & Technology

Market Closed - Nasdaq 04:00:00 2024-04-19 pm EDT 5-day change 1st Jan Change
45.16 USD +1.69% Intraday chart for Simulations Plus, Inc. -2.92% +0.92%

Business Summary

Simulations Plus, Inc. is a provider of modeling and simulation software and services for pharmaceutical drug discovery and development, including the prediction of properties of molecules utilizing both artificial intelligence and machine-based technology. The Company's segments include software and services. It offers 12 software products for pharmaceutical research and development: GastroPlus, DDDPlus, MembranePlus, DILIsym, NAFLDsym, ILDsym, IPFsym, RENAsym, MITOsym, MonolixSuite, ADMET Predictor and MedChem Designer. Its services include population pharmacokinetic and pharmacodynamic, quantitative systems pharmacology/quantitative systems toxicology, and physiologically based pharmacokinetic. The Company provides consulting services ranging from early drug discovery through preclinical and clinical trial development to regulatory submissions supporting product approval. Its software and consulting services are provided to various industries, including biotechnology and cosmetics.

Number of employees: 195

Sales per Business

USD in Million2022Weight2023Weight Delta
Software
61.3 %
33 60.6 % 37 61.3 % +11.87%
Services
38.7 %
21 39.4 % 23 38.7 % +8.45%

Sales per region

USD in Million2022Weight2023Weight Delta
Americas
68.5 %
38 69.9 % 41 68.5 % +8.32%
EMEA
19.7 %
10 19.3 % 12 19.7 % +12.76%
Asia Pacific
11.8 %
6 10.8 % 7 11.8 % +20.73%

Managers

Managers TitleAgeSince
Chief Executive Officer 65 18-06-25
Founder 79 96-07-16
Director of Finance/CFO 61 20-11-30
Chief Tech/Sci/R&D Officer - 20-08-31
Chief Tech/Sci/R&D Officer - 04-12-31
Investor Relations Contact - -
Sales & Marketing - 22-12-31
Human Resources Officer - 20-06-30
Comptroller/Controller/Auditor - 22-02-28
Corporate Officer/Principal - 19-02-28

Members of the board

Members of the board TitleAgeSince
Founder 79 96-07-16
Director/Board Member 74 17-04-30
Director/Board Member 56 14-12-02
Director/Board Member 71 19-04-30
Director/Board Member - 21-10-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 19,984,945 16,210,623 ( 81.11 %) 0 81.11 %

Shareholders

NameEquities%Valuation
3,600,195 18.03 % 148 M $
BlackRock Advisors LLC
12.04 %
2,404,558 12.04 % 99 M $
Conestoga Capital Advisors LLC
11.31 %
2,259,176 11.31 % 93 M $
LB Hercules Holdings LLC
6.615 %
1,320,723 6.615 % 54 M $
Vanguard Fiduciary Trust Co.
5.622 %
1,122,469 5.622 % 46 M $
Ranger Investment Management LP
4.663 %
931,132 4.663 % 38 M $
601,400 3.012 % 25 M $
Invesco Advisers, Inc.
2.310 %
461,311 2.310 % 19 M $
Ameriprise Financial Services LLC
2.172 %
433,604 2.172 % 18 M $
Geode Capital Management LLC
1.945 %
388,271 1.945 % 16 M $

Company contact information

Simulations Plus, Inc.

42505 10th Street West

93534-7059, Lancaster

+

http://www.simulations-plus.com
address Simulations Plus, Inc.(SLP)
  1. Stock Market
  2. Equities
  3. SLP Stock
  4. Company Simulations Plus, Inc.